SDHC phaeochromocytoma and paraganglioma: A UK‐wide case series

Autor: Williams, S.T., Chatzikyriakou, P., Carroll, P.V., McGowan, B.M., Velusamy, A., White, G., Obholzer, R., Akker, S., Tufton, N., Casey, R.T., Maher, E.R., Park, S., Porteous, M., Dyer, R., Tan, T., Wernig, F., Brady, A.F., Kosicka‐Slawinska, M., Whitelaw, B.C., Dorkins, H., Lalloo, F., Brennan, P., Carlow, J., Martin, R., Mitchell, A.L., Harrison, R., Hawkes, L., Newell‐Price, J., Kelsall, A., Igbokwe, R., Adlard, J., Schirwani, S., Davidson, R., Morrison, P.J., Chung, T., Bowles, C., Izatt, L.

Objective\ud \ud Phaeochromocytomas and paragangliomas (PPGL) are rare, but strongly heritable tumours. Variants in succinate dehydrogenase (SDH) subunits are identified in approximately 25% of cases. However, clinical and genetic information of pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::d05ff1c0c9d6171d10d57c91bd2cd686
https://eprints.whiterose.ac.uk/180578/1/Accepted_Final_Proof_CEN-2021-000450.R1_hi.pdf

SDHC phaeochromocytoma and paraganglioma: A UK-wide case series.

Autor: Williams ST; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; Department Medical Molecular Genetics, King's College London, Guy's Hospital, London, UK., Chatzikyriakou P; Department Medical Molecular Genetics, King's College London, Guy's Hospital, London, UK., Carroll PV; Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK., McGowan BM; Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Velusamy A; Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK., White G; Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Obholzer R; Department of Ear, Nose, Throat Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK., Akker S; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Foundation Trust, Cambridge, UK., Tufton N; Department of Endocrinology, St Bartholomew's Hospital, Barts Health NHS Foundation Trust, Cambridge, UK., Casey RT; Department of Endocrinology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.; Department of Medical Genetics, University of Cambridge, Cambridge, UK., Maher ER; Department of Medical Genetics, University of Cambridge, Cambridge, UK., Park SM; Department of Clinical Genetics, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK., Porteous M; South East Scotland Genetic Service, Western General Hospital, Edinburgh, Scotland, UK., Dyer R; South East Scotland Genetic Service, Western General Hospital, Edinburgh, Scotland, UK., Tan T; Imperial Centre for Endocrinology, Imperial College Healthcare NHS Trust, London, UK., Wernig F; Imperial Centre for Endocrinology, Imperial College Healthcare NHS Trust, London, UK., Brady AF; North West Thames Regional Genetics Service, Northwick Park Hospital, London, UK., Kosicka-Slawinska M; North West Thames Regional Genetics Service, Northwick Park Hospital, London, UK., Whitelaw BC; Department of Endocrinology, King's College Hospital, London, UK., Dorkins H; Department of Clinical Genetics, Leicester Royal Infirmary, Leicester, UK., Lalloo F; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, UK., Brennan P; Northern Genetics Service, Newcastle Hospitals NHS Foundation Trust, Newcastle, UK., Carlow J; Northern Genetics Service, Newcastle Hospitals NHS Foundation Trust, Newcastle, UK., Martin R; Northern Genetics Service, Newcastle Hospitals NHS Foundation Trust, Newcastle, UK., Mitchell AL; Department of Endocrinology, Newcastle upon Tyne NHS Hospitals Foundation Trust, Newcastle, UK., Harrison R; Department of Clinical Genetics, Nottingham University Hospitals NHS Trust, Nottingham, UK., Hawkes L; Department of Clinical Genetics, Churchill Hospital, Oxford, UK., Newell-Price J; Department of Oncology and Metabolism, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Kelsall A; Department of Oncology and Metabolism, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Igbokwe R; Department of Clinical Genetics, Birmingham Women's Hospital, Birmingham, UK., Adlard J; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK., Schirwani S; Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, UK., Davidson R; Department of Clinical Genetics, Queen Elizabeth University Hospital, Glasgow, Scotland, UK., Morrison PJ; Department of Medical Genetics, Belfast City Hospital, Belfast, Northern Ireland, UK., Chung TT; Department of Endocrinology, University College London Hospital NHS Foundation Trust, London, UK., Bowles C; Exeter Genomics Laboratory, Royal Devon and Exeter Hospital, Exeter, UK., Izatt L; Department Medical Molecular Genetics, King's College London, Guy's Hospital, London, UK.; Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Publikováno v: Clinical endocrinology [Clin Endocrinol (Oxf)] 2022 Apr; Vol. 96 (4), pp. 499-512. Date of Electronic Publication: 2021 Sep 24.

Sequential chemotherapy followed by radical thoracic radiotherapy (50 Gy in 25 fractions) in limited stage small cell lung cancer.

Autor: Iqbal MS; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom., Carlow J; Newcastle University, Newcastle upon Tyne, United Kingdom., McDonald F; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom., Atherton P; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom., Turnbull H; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom., Singhal S; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom., Simmons T; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom., Mulvenna P; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom., Kovarik J; Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom., McMenemin R; Department of Clinical Oncology, Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN, United Kingdom., Gardiner J; Department of Medical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom., Greystoke A; Department of Medical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, United Kingdom.

Publikováno v: Ecancermedicalscience [Ecancermedicalscience] 2020 Mar 09; Vol. 14, pp. 1019. Date of Electronic Publication: 2020 Mar 09 (Print Publication: 2020).

Emerging Medical Technologies and Their Use in Bionic Repair and Human Augmentation.

Autor: Manero, Albert^1,2 (AUTHOR) qiushi.fu@ucf.edu, Rivera, Viviana¹ (AUTHOR), Fu, Qiushi^2,3 (AUTHOR) kcrawford@ucf.edu, Schwartzman, Jonathan D.⁴ (AUTHOR) jo535595@ucf.edu, Prock-Gibbs, Hannah⁴ (AUTHOR) hprock@knights.ucf.edu, Shah, Neel⁴ (AUTHOR) neel.shah264@knights.ucf.edu, Gandhi, Deep⁴ (AUTHOR) deep.gandhi@knights.ucf.edu, White, Evan⁴ (AUTHOR) ev363752@ucf.edu, Crawford, Kaitlyn E.^2,5 (AUTHOR), Coathup, Melanie J.^2,4 (AUTHOR) melanie.coathup@ucf.edu

Publikováno v: Bioengineering (Basel). Jul2024, Vol. 11 Issue 7, p695. 36p.

Self‐Confined Dewetting Mechanism in Wafer‐Scale Patterning of Gold Nanoparticle Arrays with Strong Surface Lattice Resonance for Plasmonic Sensing.

Autor: Chen, Zhiming^1,2 (AUTHOR), Cao, An¹ (AUTHOR), Liu, Dilong^1,3 (AUTHOR) dlliu@issp.ac.cn, Zhu, Zhaoting^1,2 (AUTHOR), Yang, Fan¹ (AUTHOR), Fan, Yulong⁴ (AUTHOR), Liu, Rui¹ (AUTHOR), Huang, Zhulin¹ (AUTHOR), Li, Yue¹ (AUTHOR) yueli@issp.ac.cn

Publikováno v: Advanced Science. 3/27/2024, Vol. 11 Issue 12, p1-10. 10p.